News Callitas Health Inc.

Equities

MPHMF

CA13125C1068

Market Closed - OTC Markets Other stock markets 08:35:17 01/03/2024 pm IST			5-day change	1st Jan Change
0.0001 ^USD	+9,900.00%		-.--%	+9,900.00%

2018	James Thompson to Assume the Position of President and Chief Executive Officer of Callitas Health Inc	CI
2018	Callitas Health Inc. Announces Management Changes	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

James Thompson to Assume the Position of President and Chief Executive Officer of Callitas Health Inc	07/18/07	CI
Callitas Health Inc. Announces Management Changes	04/18/04	CI
M Pharmaceutical Inc. Appoints Gary Thompson as President and CEO	13/17/13	CI
M Pharmaceutical Inc. announced that it expects to receive CAD 0.7 million in funding	06/16/06	CI
M Pharmaceutical Inc. Appoints Brian Keane as Interim President and CEO	04/16/04	CI
M Pharmaceutical Inc. Announces Resignation of Mathew Lehman as President, CEO and from the Board of Directors	15/16/15	CI
M Pharmaceutical Inc. (DB:T3F1) cancelled the sale of Remaining Oil and Gas Assets.	19/16/19	CI
M Pharmaceutical, Inc. Announces Resignation of Martin Mintchev from the Board of Directors and as Chief Scientific Officer	16/15/16	CI
M Pharmaceutical Inc. (DB:T3F2) entered into letter of intent to acquire reformulated orlistat for weight loss from Chelatexx, LLC for CAD 1.30 million.	20/15/20	CI
M Pharmaceutical In Acquisition Talks	21/15/21	CI
M Pharmaceutical Inc. Announces Management Changes	19/15/19	CI
M Pharmaceutical Inc. to Open a Fully Owned Subsidiary in Sofia, Bulgaria	18/15/18	CI
Rishena Enters Into Manufacturing Supply Agreement for Production of Trimtec Gastric Stimulation Device	18/15/18	CI
M Pharmaceutical Inc. Appoints Oliver Frank Bathe to its Advisory Board	17/15/17	CI
M Pharmaceutical Inc. announced that it expects to receive CAD 0.35 million in funding.	07/15/07	CI
M Pharmaceutical Inc. (DB:T3F1) completed the acquisition of Trimtec Biomedical Inc.	26/15/26	CI
M Pharmaceutical Inc Appoints Dr. Michel Fattouche to Advisory Board	19/15/19	CI
M Pharmaceutical Inc. Appoints Orly Yadid-Pecht to its Advisory Board	17/15/17	CI
M Pharmaceutical Inc. Appoints Christopher Andrews to Board of Directors	14/15/14	CI
M Pharmaceutical Inc. (DB:T3F1) entered into an agreement to acquire Trimtec Biomedical Inc.	07/15/07	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Callitas Health Inc.

Equities

MPHMF

CA13125C1068

Summary

Filters